Evidence for pathogenicity of autoreactive T cells in autoimmune bullous diseases shown by animal disease models

Experimental Dermatology

Volumn 21, Issue 12, 2012, Pages 901-905

  Ujiie, Hideyuki ^a   Shimizu, Hiroshi ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Active model; Bullous pemphigoid; Costimulatory molecule; Epidermolysis bullosa acquisita; Pemphigus vulgaris

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; CYCLOSPORIN A; HLA DQB1 ANTIGEN; HLA DR2 ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADOPTIVE TRANSFER; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE BULLOUS DISEASE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; BULLOUS PEMPHIGOID; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL INTERACTION; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; EPIDERMOLYSIS BULLOSA ACQUISITA; GENE EXPRESSION; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE FUNCTION; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NONHUMAN; PATHOGENESIS; PATHOGENICITY; PEMPHIGUS; RECEPTOR BINDING; REGULATORY T LYMPHOCYTE; SKIN DISEASE; T LYMPHOCYTE;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; EPIDERMOLYSIS BULLOSA ACQUISITA; EVIDENCE-BASED MEDICINE; HUMANS; MICE; PEMPHIGOID, BULLOUS; PEMPHIGUS; T-LYMPHOCYTES;

EID: 84870054753     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12011     Document Type: Article

References (91)

1. McMillan J R, Akiyama M, Shimizu H. J Dermatol Sci 2003: 31: 169-177.
2. Diaz L A, Ratrie H III, Saunders W S et al. J Clin Invest 1990: 86: 1088-1094.
3. Ishiko A, Shimizu H, Kikuchi A et al. J Clin Invest 1993: 91: 1608-1615.
4. Bedane C, McMillan J R, Balding S D et al. J Invest Dermatol 1997: 108: 901-907.
5. Nishie W, Sawamura D, Goto M et al. Nat Med 2007: 13: 378-383.
6. Nishie W, Sawamura D, Natsuga K et al. J Immunol 2009: 183: 4088-4093.
7. Liu Z, Diaz L A, Troy J L et al. J Clin Invest 1993: 92: 2480-2488.
8. Liu Z, Giudice G J, Swartz S J et al. J Clin Invest 1995: 95: 1539-1544.
9. Liu Z, Giudice G J, Zhou X et al. J Clin Invest 1997: 100: 1256-1263.
10. Ujiie H, Nishie W, Shimizu H. Dermatol Clin 2011: 29: 439-446.
11. Ujiie H, Shibaki A, Nishie W et al. J Dermatol 2010: 37: 194-204.
12. Giudice G J, Emery D J, Zelickson B D et al. J Immunol 1993: 151: 5742-5750.
13. Li Q, Ujiie H, Shibaki A et al. J Immunol 2010: 185: 7746-7755.
14. Wang G, Ujiie H, Shibaki A et al. Am J Pathol 2010: 176: 914-925.
15. Liu Z, Sui W, Zhao M et al. J Autoimmun 2008: 31: 331-338.
16. Amagai M, Klaus-Kovtun V, Stanley J R. Cell 1991: 67: 869-877.
17. Stanley J R, Amagai M. N Engl J Med 2006: 355: 1800-1810.
18. Amagai M, Tsunoda K, Suzuki H et al. J Clin Invest 2000: 105: 625-631.
19. Woodley D T, Briggaman R A, O'Keefe E J et al. N Engl J Med 1984: 310: 1007-1013.
20. Stanley J R, Rubinstein N, Klaus-Kovtun V. J Invest Dermatol 1985: 85: 542-545.
21. Gammon W R, Murrell D F, Jenison M W et al. J Invest Dermatol 1993: 100: 618-622.
22. Chen M, Keene D R, Costa F K et al. J Biol Chem 2001: 276: 21649-21655.
23. Goodnow C C, Vinuesa C G, Randall K L et al. Nat Immunol 2010: 11: 681-688.
24. Budinger L, Borradori L, Yee C et al. J Clin Invest 1998: 102: 2082-2089.
25. Lin M S, Fu C L, Giudice G J et al. J Invest Dermatol 2000: 115: 955-961.
26. Hertl M, Amagai M, Sundaram H et al. J Invest Dermatol 1998: 110: 62-66.
27. Lin M S, Swartz S J, Lopez A et al. J Clin Invest 1997: 99: 31-40.
28. Muller R, Dahler C, Mobs C et al. Clin Immunol 2010: 135: 99-107.
29. Schmidt E, Bastian B, Dummer R et al. Arch Dermatol Res 1996: 288: 353-357.
30. Ameglio F, D'Auria L, Bonifati C et al. Br J Dermatol 1998: 138: 611-614.
31. Wakugawa M, Nakamura K, Hino H et al. Br J Dermatol 2000: 143: 112-116.
32. Teraki Y, Hotta T, Shiohara T. J Invest Dermatol 2001: 117: 1097-1102.
33. Eming R, Budinger L, Riechers R et al. Br J Dermatol 2000: 143: 1279-1282.
34. Delgado J C, Turbay D, Yunis E J et al. Proc Natl Acad Sci USA 1996: 93: 8569-8571.
35. Lombardi M L, Mercuro O, Tecame G et al. Tissue Antigens 1996: 47: 228-230.
36. Gonzalez-Escribano M F, Jimenez G, Walter K et al. Tissue Antigens 1998: 52: 275-278.
37. Loiseau P, Lecleach L, Prost C et al. J Autoimmun 2000: 15: 67-73.
38. Saha M, Harman K, Mortimer N J et al. J Invest Dermatol 2010: 130: 311-314.
39. Miyagawa S, Higashimine I, Iida T et al. J Invest Dermatol 1997: 109: 615-618.
40. Gammon W R, Heise E R, Burke W A et al. J Invest Dermatol 1988: 91: 228-232.
41. Lee C W, Kim S C, Han H. Dermatology 1996: 193: 328-329.
42. Zumelzu C, Le Roux-Villet C, Loiseau P et al. J Invest Dermatol 2011: 131: 2386-2393.
43. Ujiie H, Shibaki A, Nishie W et al. J Immunol 2010: 184: 2166-2174.
44. Avalos-Diaz E, Lopez-Robles E, Alvarado-Flores E et al. Exp Dermatol 2008: 17: 44-48.
45. Sitaru C, Chiriac M T, Mihai S et al. J Immunol 2006: 177: 3461-3468.
46. Ludwig R J, Recke A, Bieber K et al. J Invest Dermatol 2011: 131: 167-176.
47. Hirose M, Recke A, Beckmann T et al. J Immunol 2011: 187: 1176-1183.
48. Olasz E B, Roh J, Yee C L et al. J Invest Dermatol 2007: 127: 2807-2817.
49. Ujiie H, Shibaki A, Nishie W et al. Clin Immunol 2012: 142: 167-175.
50. Tsunoda K, Ota T, Suzuki H et al. Eur J Immunol 2002: 32: 627-633.
51. Takahashi H, Amagai M, Nishikawa T et al. J Immunol 2008: 181: 1526-1535.
52. Sitaru A G, Sesarman A, Mihai S et al. J Immunol 2010: 184: 1596-1603.
53. Kasperkiewicz M, Muller R, Manz R et al. Blood 2011: 117: 6135-6142.
54. Hammers C M, Bieber K, Kalies K et al. J Immunol 2011: 187: 5043-5050.
55. Abbas A K, Murphy K M, Sher A. Nature 1996: 383: 787-793.
56. Chan A C, Carter P J. Nat Rev Immunol 2010: 10: 301-316.
57. Reichert J M. MAbs 2011: 3: 76-99.
58. Haufs M G, Haneke E. Acta Derm Venereol 2001: 81: 72.
59. Mockenhaupt M, Grosber M, Norganer J. Acta Derm Venereol 2005: 85: 65-66.
60. Renkl A, Mockenhaupt M, Technau K et al. Br J Dermatol 2004: 150: 1220-1222.
61. Alijotas J, Pedragosa R, Bosch J et al. J Am Acad Dermatol 1990: 23: 701-703.
62. Curley R K, Holden C A. Clin Exp Dermatol 1991: 16: 68-69.
63. Khatri M L, Benghazeil M, Shafi M. J Eur Acad Dermatol Venereol 2001: 15: 182-184.
64. Takae Y, Nishikawa T, Amagai M. Exp Dermatol 2008: 18: 252-260.
65. Chrysomallis F, Ioannides D, Teknetzis A et al. Int J Dermatol 1994: 33: 803-807.
66. Ioannides D, Chrysomallis F, Bystryn J C. Arch Dermatol 2000: 136: 868-872.
67. Peters A L, Stunz L L, Bishop G A. Semin Immunol 2009: 21: 293-300.
68. Im S H, Barchan D, Maiti P K et al. J Immunol 2001: 166: 6893-6898.
69. Aoki-Ota M, Kinoshita M, Ota T et al. J Invest Dermatol 2006: 126: 105-113.
70. Ohyama M, Ota T, Aoki M et al. J Invest Dermatol 2003: 120: 610-615.
71. Lanschuetzer C M, Olasz E B, Lazarova Z et al. J Invest Dermatol 2009: 129: 1203-1207.
72. Howard L M, Miga A J, Vanderlugt C L et al. J Clin Invest 1999: 103: 281-290.
73. Kalled S L, Cutler A H, Datta S K et al. J Immunol 1998: 160: 2158-2165.
74. Quezada S A, Eckert M, Adeyi O A et al. Arthritis Rheum 2003: 48: 2541-2554.
75. Di Zenzo G, Grosso F, Terracina M et al. J Invest Dermatol 2004: 122: 103-110.
76. Di Zenzo G, Thoma-Uszynski S, Calabresi V et al. J Invest Dermatol 2011: 131: 2271-2280.
77. Di Zenzo G, Thoma-Uszynski S, Fontao L et al. Clin Immunol 2008: 128: 415-426.
78. Salato V K, Hacker-Foegen M K, Lazarova Z et al. Clin Immunol 2005: 116: 54-64.
79. Yokoyama T, Amagai M. J Dermatol 2010: 37: 205-213.
80. Veldman C M, Gebhard K L, Uter W et al. J Immunol 2004: 172: 3883-3892.
81. Rensing-Ehl A, Gaus B, Bruckner-Tuderman L et al. Exp Dermatol 2007: 16: 13-21.
82. Arakawa M, Dainichi T, Ishii N et al. Exp Dermatol 2011: 20: 1022-1024.
83. Veldman C, Hohne A, Dieckmann D et al. J Immunol 2004: 172: 6468-6475.
84. Veldman C, Nagel A, Hertl M. Int Arch Allergy Immunol 2006: 140: 174-183.
85. Yokoyama T, Matsuda S, Takae Y et al. Int Immunol 2011: 23: 365-373.
86. Chen L, Peterson J D, Zheng W Y et al. Clin Exp Immunol 2006: 145: 322-331.
87. Steinman L. Science 2004: 305: 212-216.
88. Ettinger M, Peckl-Schmid D, Gruber C, et al. J Invest Dermatol 2012: 132: 1665-1671.
89. Ruiz P J, Garren H, Ruiz I U et al. J Immunol 1999: 162: 3336-3341.
90. Goudy K S, Wang B, Tisch R. Clin Immunol 2008: 129: 49-57.
91. Hertl M, Eming R, Veldman C. J Clin Invest 2006: 116: 1159-1166.